Lung cancer: the key multidisciplinary approach
Valuable team work together with you by ERS, ATS, ESR, ESTS, ESTRO and IASLC – the diagnostic part
Registration for this session is additional to the congress registration fee and is: €170.5 early bird; €220 standard and €242 on site.
Aims : due to the rapid development of novel diagnostic and therapeutic approaches, lung cancer is gradually losing its stigma of being an incurable disease. Although unthinkable for a long time, chronification of lung cancer has become a realistic vision for the future. Moreover, current diagnostic and therapeutic approaches can substantially improve the prognosis of lung cancer patients. Close interactions and multidisciplinary teamwork are key to deliver the best care for patients with lung cancer, which is a highly complex disease